Cancer Diagnostics Market Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin), By Region, And Segment Forecasts, 2014 - 2025

  • ID: 4209701
  • Report
  • 90 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Hologic,Inc.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • MORE
The global cancer diagnostics market is expected to reach USD 232.7 billion by 2025. Continual introduction of innovative products coupled with increasing need for early diagnosis of the disease is the prime factor driving the market growth. In addition, rapid growth of the sector is attributed to the penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering the demand for these screening tests and imaging modalities that are used for monitoring disease progression.

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early diagnosis of the disease. In addition, cancer research organizations along with public and private entities are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease way before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility of their products. For instance, Illumina, Inc. launched a new venture named GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than $100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.

Further Key Findings from the Study Suggest:

Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of the imaging systems space. Thus, the segment is expected to grow at the fastest CAGR at over 8.0% during the forecast period.

The breast cancer segment, among other application segments, accounted for the largest share due to the high incidence rate of breast cancer triggering the need for its early diagnosis.

In 2016, North America dominated the global space with the largest revenue share of more than 41%. Focused research efforts in oncology for the development of early tumor detection tools coupled with grants from government healthcare agencies are contributing to a strong medical ecosystem to fight cancer in this region.

Asia Pacific is expected to emerge as the fastest growing region during the forecast period. The growing patient pool in India, China, and Japan; due to the support in diagnostic process at comparatively lower prices; and a favorable regulatory framework are some of the factors boosting the market growth in this region.

Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd and Siemens Healthcare GmbH. Other prominent players operating in the market include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; .and Hologic, Inc.
PLEASE NOTE: This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Hologic,Inc.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • MORE
1 Research Methodology
1.1 Information procurement
1.2 Data Analysis
1.3 Approaches for market estimation
1.3.1 Approach 1: Demand Analysis & Bottom up Approach
1.3.2 Approach 2: Top down market estimation
1.3.3 Approach 3: Commodity flow and bottom up market estimation
1.3.4 Approach 4: KoL perspective based market sizing

2 Executive Summary
2.1 Market Snapshot

3 Cancer Diagnostics Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.2 Market Driver Analysis
3.2.1 Rising prevalence of cancer cases
3.2.2 Technological advancement
3.2.3 Initiatives undertaken by government
3.2.4 Reimbursement coverage
3.3 Market Restraints Analysis
3.3.1 Lack of sensitivity and specificity
3.3.2 Risk of high radiation exposure used in different treatments
3.3.3 Cost of diagnosis
3.4 Penetration & growth prospect mapping
3.5 Cancer Diagnostics - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter’s

4 Cancer Diagnostics: Screening Type Estimates & Trend Analysis
4.1 Cancer Diagnostics Market: Screening Type movement analysis
4.1.1. Laboratory Tests
4.1.1.1 Laboratory Tests Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
4.1.2 Genetic Tests
4.1.2.1 Genetic Tests Market Estimates and Forecasts, 2014 - 2025 (USD Billion))
4.1.3 Imaging
4.1.3.1 Imaging Market Estimates and Forecasts, 2014 - 2025 (USD Billion))
4.1.4 Endoscopy
4.1.4.1 Endoscopy Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
4.1.5 Biopsy
4.1.5.1 Biopsy Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
4.1.6 Others ( Barium Enema)
4.1.6.1 Others Market Estimates and Forecasts, 2014 - 2025 (USD Billion)

5 Cancer Diagnostics: Application Estimates & Trend Analysis
5.1 Cancer Diagnostics Market: Application movement analysis
5.1.1 Breast Cancer
5.1.1.1 Breast Cancer Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
5.1.2 Colorectal Cancer
5.1.2.1 Colorectal Cancer Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
5.1.3 Cervical Cancer
5.1.3.1 Cervical Cancer Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
5.1.4 Lung Cancer
5.1.4.1 Lung Cancer Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
5.1.5 Prostate cancer
5.1.5.1 Prostate Cancer Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
5.1.6 Skin Cancer
5.1.6.1 Skin Cancer Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
5.1.7 Blood Cancer
5.1.7.1 Blood Cancer Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
5.1.8 Kidney Cancer
5.1.8.1 Kidney Cancer Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
5.1.9 Liver Cancer
5.1.9.1 Liver Cancer Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
5.1.10 Pancreatic Cancer
5.1.10.1 Pancreatic Cancer Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
5.1.11 Ovarian Cancer
5.1.11.1 Ovarian Cancer Market Estimates and Forecasts, 2014 - 2025 (USD Billion)
5.1.12 Others
5.1.12.1 Others Market Estimates and Forecasts, 2014 - 2025 (USD Billion)

6 Cancer Diagnostics: Regional Estimates &Trend Analysis, by Screening Type & Application Type
6.1 Cancer Diagnostics Market Share By Region, 2015 & 2025
6.2 North America
6.2.1 North America Cancer Diagnostics Market, 2014 - 2025 (USD Billion)
6.2.2 U.S.
6.2.2.1 Market Estimates & Forecast, By Screening Type 2014 - 2025 (USD Billion)
6.2.2.2 Market Estimates & Forecast, By Application 2014 - 2025 (USD Billion)
6.2.3 Canada
6.2.3.1 Market Estimates & Forecast, By Screening Type 2014 - 2025 (USD Billion)
6.2.3.2 Market Estimates & Forecast, By Application 2014 - 2025 (USD Billion)
6.3 Europe
6.3.1 Europe Cancer Diagnostics Market, 2014 - 2025 (USD Billion)
6.3.2 UK
6.3.2.1 Market Estimates & Forecast, By Screening Type 2014 - 2025 (USD Billion)
6.3.2.2 Market Estimates & Forecast, By Application 2014 - 2025 (USD Billion)
6.3.3 Germany
6.3.3.1 Market Estimates & Forecast, By Screening Type 2014 - 2025 (USD Billion)
6.3.3.2 Market Estimates & Forecast, By Application 2014 - 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Cancer Diagnostics Market, 2014 - 2025 (USD Billion)
6.4.2 Japan
6.3.2.1 Market Estimates & Forecast, By Screening Type 2014 - 2025 (USD Billion)
6.3.2.2 Market Estimates & Forecast, By Application 2014 - 2025 (USD Billion)
6.4.3 China
6.3.3.1 Market Estimates & Forecast, By Screening Type 2014 - 2025 (USD Billion)
6.3.3.2 Market Estimates & Forecast, By Application 2014 - 2025 (USD Billion)
6.5 Latin America
6.5.1 Latin America Cancer Diagnostics Market, 2014 - 2025 (USD Billion)
6.5.2 Brazil
6.5.2.1 Market Estimates & forecast, By Screening Type 2014 - 2025 (USD Billion)
6.5.2.2 Market Estimates & Forecast, By Application 2014 - 2025 (USD Billion)
6.5.3 Mexico
6.5.3.1 Market Estimates & Forecast, By Screening Type 2014 - 2025 (USD Billion)
6.5.3.2 Market Estimates & Forecast, By Application 2014 - 2025 (USD Billion)
6.6 MEA
6.6.1 MEA Cancer Diagnostics Market, 2014 - 2025 (USD Billion)
6.6.2 South Africa
6.6.2.1 Market Estimates & Forecast, By Screening Type 2014 - 2025 (USD Billion)
6.6.2.2 Market Estimates & Forecast, By Application 2014 - 2025 (USD Billion)

7 Competitive Landscape
7.1 Abbott
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Qiagen
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Siemens Healthcare GmbH
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 GE Healthcare
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Hologic,Inc.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Koninklijke Philips N.V.
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
7.10 Illumina, Inc.
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives

List of Tables

Table 1 North America Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
Table 2 North America Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
Table 3 U.S. Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
Table 4 U.S. Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
Table 5 Canada Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
Table 6 Canada Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
Table 7 Europe Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
Table 8 Europe Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
Table 9 UK Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
Table 10 UK Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
Table 11 Germany Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
Table 12 Germany Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
Table 13 Asia Pacific Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
Table 14 Asia Pacific Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
Table 15 Japan Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USDBillion);
Table 16 Japan Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
Table 17 China Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
Table 18 China Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
Table 19 Latin America Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
Table 20 Latin America Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
Table 21 Brazil Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USDBillion)
Table 22 Brazil Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
Table 23 Mexico Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
Table 24 Mexico Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
Table 25 MEA Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
Table 26 MEA Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
Table 27 South Africa Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
Table 28 South Africa Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 Market summary
Figure 8 Market trends & outlook
Figure 9 Market segmentation & scope
Figure 10 Market driver relevance analysis (Current & future impact)
Figure 11 Market driver relevance analysis (Current & future impact)
Figure 12 Penetration & Growth prospect mapping
Figure 13 SWOT Analysis, By Factor (political & legal, economic and technological)
Figure 14 Porter’s Five Forces Analysis
Figure 15 Cancer Diagnostics Market product outlook key takeaways
Figure 16 Cancer Diagnostics: Screening Type movement analysis
Figure 17 Laboratory Tests Market, 2014 - 2025 (USDBillion)
Figure 18 Genetic Tests Market, 2014 - 2025 (USD Billion)
Figure 19 Imaging Market, 2014 - 2025 (USD Billion)
Figure 20 Endoscopy Market, 2014 - 2025 (USD Billion)
Figure 21 BiopsyMarket, 2014 - 2025 (USD Billion
Figure 22 Others Market, 2014 - 2025 (USDBillion)
Figure 23 Cancer Diagnostics market Application outlook key takeaways
Figure 24 Cancer Diagnostics : Application movement analysis
Figure 25 Breast Cancer Market, 2014 - 2025 (USD Billion)
Figure 26 Colorectal Cancer Market, 2014 - 2025 (USD Billion)
Figure 27 Cervical Cancer Market, 2014 - 2025 (USD Billion)
Figure 28 Lung Cancer Market, 2014 - 2025 (USD Billion)
Figure 29 Prostate Cancer Market, 2014 - 2025 (USD Billion)
Figure 30 Skin Cancer Market, 2014 - 2025 (USDBillion)
Figure 31 Blood Cancer Market, 2014 - 2025 (USDBillion)
Figure 32 Kidney Cancer Market, 2014 - 2025 (USD Billion)
Figure 33 Liver Cancer Market, 2014 - 2025 (USD Billion)
Figure 34 Pancreatic Cancer Market, 2014 - 2025 (USD Billion)
Figure 35 Ovarian Cancer Market, 2014 - 2025 (USD Billion)
Figure 36 Others Market, 2014 - 2025 (USD Billion)
Figure 37 Regional market place: Key takeaways
Figure 38 Strategy framework
Figure 39 Participant categorization
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott
  • Qiagen
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • Hologic,Inc.
  • Becton, Dickinson and Company
  • Koninklijke Philips N.V.
  • Illumina, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll